文献速递心律失常心力衰竭与心肌病

频发室性早搏与房颤、心衰、卒中及死亡风险:一项荟萃分析

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis.
PubMed 文献 · Heart · 2025-11-25

该荟萃分析纳入17项研究共26 783 590名无明确心血管疾病的成人,评估频发室性早搏(PVC)与房颤、心衰、卒中及全因死亡风险的关联。结果显示频发PVC显著增加房颤(HR 1.69)、心衰(HR 1.73)、卒中(HR 1.28)和全因死亡(HR 1.31)风险。PVC负荷每增加1%,房颤风险增加5.4%。

要点

  • 频发PVC显著增加房颤、心衰、卒中和全因死亡风险。
  • PVC负荷每增加1%,房颤风险增加5.4%。
  • 频发PVC(≥500/天)患者或需定期超声心动图和节律监测。

核心结论

  • 在大多无明确结构性心脏病的人群中,频发PVC显著增加房颤、心衰、卒中和全因死亡风险。
  • 频发PVC(≥500/天)患者可能受益于定期超声心动图和节律监测,以早期发现结构或心律失常进展。

研究设计与样本

  • 检索PubMed/MEDLINE、Embase、CENTRAL、Web of Science和Scopus至2025年2月,纳入采用标准化PVC评估方法、至少12个月随访并报告调整效应量的研究。
  • 共分析20篇文章(17项研究;26 783 590名参与者),采用随机效应荟萃分析计算合并HR及95%CI和预测区间(PI),并进行meta回归评估剂量反应关系。

主要发现

  • 频发PVC与房颤风险显著增加相关(HR 1.69,95%CI 1.39-2.05;PI 0.91-3.12)。
  • 频发PVC与心衰风险显著增加相关(HR 1.73,95%CI 1.50-2.00;PI 1.18-2.54)。
  • 频发PVC与卒中风险显著增加相关(HR 1.28,95%CI 1.10-1.50;PI 0.90-1.82)。
  • 频发PVC与全因死亡风险显著增加相关(HR 1.31,95%CI 1.10-1.56;PI 0.79-2.18)。
  • Meta回归显示PVC负荷每增加1%,房颤风险增加5.4%。

关键数值与推荐

  • 频发PVC(≥500/天)可能受益于定期超声心动图和节律监测。
  • PVC负荷每增加1%,房颤风险增加5.4%。

临床怎么用

  • 对频发PVC(≥500/天)患者,考虑定期超声心动图和节律监测以早期发现结构或心律失常进展。
  • 在无明确结构性心脏病的人群中,频发PVC应被视为心血管风险增加的标志,而非良性现象。

局限性

  • 各研究基线心脏评估方法存在差异。
  • 需要随机试验确定以PVC负荷为指导的干预能否降低心血管风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND/AIM: Frequent premature ventricular complexes (PVCs) have historically been regarded as benign in structurally normal hearts, yet emerging evidence suggests substantial cardiovascular risk. This meta-analysis aimed to quantify associations between frequent PVCs and incident atrial fibrillation, heart failure, stroke and all-cause mortality in adults without established cardiovascular disease. METHODS: PubMed/MEDLINE, Embase, CENTRAL, Web of Science and Scopus were searched through February 2025. Databases were searched from inception to February 2025. Eligible studies employed standardised PVC assessment methods with a minimum 12-month follow-up reporting adjusted effect estimates. Data were independently extracted and quality was assessed (Risk of Bias in Non-randomized Studies of Interventions) by two reviewers. Random-effects meta-analyses yielded pooled HRs with 95% CIs and prediction intervals (PI). Study-level meta-regression was used to evaluate dose-response relationships, and heterogeneity sources were explored via further meta-regression. OUTCOMES: 20 articles (17 studies; 26 783 590 participants) were analysed. Frequent PVCs were significantly associated with increased risks of atrial fibrillation (HR 1.69, 95% CI 1.39 to 2.05; PI 0.91-3.12), heart failure (HR 1.73, 95% CI 1.50 to 2.00; PI 1.18-2.54), stroke (HR 1.28, 95% CI 1.10 to 1.50; PI 0.90-1.82) and all-cause mortality (HR 1.31, 95% CI 1.10 to 1.56; PI 0.79-2.18). Heterogeneity was substantially reduced in sensitivity analyses restricted to Holter-quantified PVCs. Meta-regression identified a 5.4% increased atrial fibrillation risk per 1% increment in PVC burden. CONCLUSION: Frequent PVCs confer significantly increased cardiovascular risks in populations largely without overt structural heart disease, though baseline cardiac assessment varied across studies. Patients with frequent PVCs (≥500/day) may benefit from periodic echocardiography and rhythm monitoring to detect early structural or arrhythmic progression. Randomised trials are needed to determine if PVC burden-guided interventions can reduce cardiovascular risk. PROSPERO REGISTRATION NUMBER: CRD420251006111.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Kiliç, Arayici, Yilancioglu, et al. Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis. Heart. 2025. PMID: 41052919. doi:10.1136/heartjnl-2025-326174

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。